Circulating tumor cell detection during chemotherapy in patients with breast cancer is not associated with plasma homocysteine levels

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 2937-2941

  Yoshihara, Renata Nunes ^a   Teixeira, Bianca Marinelli ^a   Adami, Fernando ^a   Kuniyoshi, Renata K ^a,b   Alves, Beatriz C A ^a   Gehrke, Flávia S ^a   Vilas Bôas, Viviane A ^a   Azzalis, Ligia A ^c   Junqueira, Virginia B C ^c   Pereira, Edimar Cristiano ^c   Fonseca, Fernando L A ^a,c  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Circulating tumor cells; Epithelial markers; Homocysteinemia; Thromboembolism

Indexed keywords

EID: 84885431624     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0856-2     Document Type: Article

References (30)

1. Instituto Nacional do Câncer. Estimativa 2012: Incidência de Câncer no Brasil. Rio de Janeiro. INCA, 2012 [in Portuguese]. Available at: http://www.inca.gov.br. Accessed December 15, 2012.
2. McGuire WL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst. 1991;83:154-5.
3. Goldhirsch A, Wood WC, Senn HJ, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst. 1995;87:1441-5.
4. Group EBCT'. Polychemotherapy for early breast cancer an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998;352:930-42.
5. Aziz DC. Thrombosis. In: Aziz DC, editor. Interpretation of laboratory tests in cardiology and coagulation. 1st ed. Santa Monica: Specialty Laboratories; 1999. p. 17-52.
6. de Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood. 1996;87:3531-44.
7. Neufeld EJ. Update on genetic risk factors for thrombosis and atherosclerotic vascular disease. Hematol Oncol Clin N Amer. 1998;12:1193-209.
8. Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, et al. Hyperhomocysteinemia in women with advanced breast cancer. Int J Lab Hematol. 2007;29:421-5.
9. Chou YC, Lee MS, Wu MH, Shih HL, Yang T, Yu CP, et al. Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat. 2007;101:199-205.
10. Ring A, Smith IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol. 2004;5:79-88.
11. Diel IJ, Cote RJ. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. Cancer Treat Rev. 2000;26:53-65.
12. Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-4.
13. Wang JY, Wu CH, Lu CY, Hsieh JS, Wu DC, Huang SY, et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg. 2006;30:1007-13.
14. Stathopoulou A, Vlachonikolis I, Mavroudis D, et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol. 2002;20:3404-12.
15. Xenidis N, Perraki M, Kafousi M, et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA positive cells detected by real-time PCR in node-negative breast cancer patients. J Clin Oncol. 2006;24:3756-62.
16. Stathopoulou A, Mavroudis D, Perraki M, et al. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 2003;23:1883-90.
17. Fonseca FL, Soares HP, Manhani AR, Bendit I, Novaes M, Zatta SM, et al. Peripheral blood c-erbB-2 expression by reverse transcriptase-polymerase chain reaction in breast cancer patients receiving chemotherapy. Clin Breast Cancer. 2002;3:201-5.
18. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781-9.
19. Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med. 2011;9:43.
20. Mengo M, De Giorgi U, Broglio K, Dawood S, Valero V, Andreopoulou E, et al. Circulating tumor cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. British J Cancer. 2009;101:1813-6.
21. Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, et al. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin Cancer Res. 2003;9:5145-51.
22. Gascón TM, Schindler F, Oliveira CGB, Souza FIS, Hix S, Sacardo RO, Bacan APA, DÁlmeida V, Del Giglio A, Fonseca FLA. (2010) Evaluation of chemiluminescence method for the analysis of plasma homocysteine and comparison with HPLC method in children samples. Einstein 2010;8:187-91.
23. Morris MS, Jacques PF, Selhub J, Rosenberg IH. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2000;152:140-8.
24. Friso S, Lamon-Fava S, Jang H, Schaefer EJ, Corrocher R, Choi SW. Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women. Br J Nutr. 2007;97:617-21.
25. Tutuncu L, Ergur AR, Mungen E, Gun I, Ertekin A, Yergok YZ. The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial. Menopause. 2005;12:216-22.
26. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S-9S.
27. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809-15.
28. Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, et al. Hyperhomocysteinemia in women with advanced breast cancer. Int J Lab Hemato. 2007;29:421-5.
29. Chou YC, Lee MS, Wu MH, Shih HL, Yang T, Yu CP, et al. Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat. 2007;101:199-205.
30. Chen Y, Zou TN, Wu ZP, Zhou YC, Gu YL, Liu X, et al. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int J Biol Markers. 2010;25:59-68.